Skip to content
MedWatchMedWatch

Anticipated shortage

Tamiflu 75 mg capsules

oseltamivir phosphate · 75 mg capsule

Tamiflu

Reported
20 January 2025
Expected resolution
31 August 2026
TGA reference
TGA-MSI-2025-001
Sponsor
Roche Products Pty Limited

Reason for shortage

Anticipated shortage due to projected influenza season demand outpacing current stock levels.

What to do

  1. 1.
    Ensure you have adequate stock — Collect your current prescription promptly to build a small buffer before the anticipated shortage begins.
  2. 2.
    Speak with your prescriber proactively — Discuss alternative options now, before the shortage occurs, so a plan is in place.
  3. 3.
    Monitor TGA updates — Anticipated shortages may be resolved before they become active. Check the TGA MSI database regularly.

Suggested alternatives

Always discuss alternative medicines with your pharmacist or doctor before switching. Listed items are from the same or a related therapeutic class — not necessarily drop-in substitutes.
  • Relenza inhaler — zanamivir 5 mg/dose (inhaled)
  • Xofluza — baloxavir marboxil (single-dose tablet, not PBS listed)

Official resources

TGA Medicine Shortage Information — oseltamivir phosphate

PBS schedule — oseltamivir phosphate

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.

Back to all shortages